Clinical Trials Register - triple negative breast cancer trial


Clinical trials for triple negative breast cancer triple negative breast cancer trial

Rugo Highlights Latest Advances in TNBC Treatment Clinical trials are now investigating a number of different avenues for patients with.

Clinical Phase Ib Trial of L-NMMA Plus Docetaxel in the Treatment of Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients.

Primary Purpose: Treatment. Official Title: Triple Negative Trial: A Randomised Phase III Trial of Carboplatin Compared to Docetaxel for Patients With Metastatic .

Neoadjuvant breast cancer clinical trials pre, including patients with triple- negative breast cancer and showing modest pathological.

Triple-negative breast cancer (TNBC) is known to have a poor prognosis and In addition, we summarize the ongoing phase III clinical trials.